The discover of Kv2.1 contribution to membrane current in MDA-MB-436 cells provides new insights into the electrophysiological properties of this TNBC model and supports the potential role of voltage-gated K+ channels as therapeutic targets in breast cancer. This evidence concerns the gene KCND3 and breast cancer.